Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists--pharmacologic considerations

L M Prisant1

  • 1Medical College of Georgia, Augusta, USA.

Ethnicity & Disease
|May 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality in patients with microvascular disease.

Journal of clinical hypertension (Greenwich, Conn.)·2004
Same author

Coarctation of the aorta: a secondary cause of hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2004
Same author

Arterial elasticity among normotensive subjects and treated and untreated hypertensive subjects.

Blood pressure monitoring·2002
Same author

Verapamil revisited: a transition in novel drug delivery systems and outcomes.

Heart disease (Hagerstown, Md.)·2002
Same author

Hypertension images: electrocardiographic left ventricular hypertrophy.

Journal of clinical hypertension (Greenwich, Conn.)·2001
Same author

Hypertension and chronotherapy: shifting the treatment paradigm.

American journal of hypertension·2001

Calcium antagonists effectively lower blood pressure and reduce angina by blocking calcium entry into cells. Extended-release formulations ensure 24-hour efficacy in diverse populations.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Calcium antagonists modulate cellular calcium influx via voltage-dependent channels.
  • Key sites include L-type (dihydropyridine, phenylalkylamine, benzothiazepine) and T-type channels.

Purpose of the Study:

  • To review the mechanisms and therapeutic applications of calcium antagonists.
  • To highlight advancements in drug delivery for sustained action.

Main Methods:

  • Review of existing literature on calcium channel blockers.
  • Analysis of tissue affinity and vascular selectivity data.
  • Evaluation of extended-release formulations.

Main Results:

  • Calcium antagonists exhibit varying tissue affinities and vascular selectivity.

Related Experiment Videos

  • Extended-release formulations provide 24-hour blood pressure control.
  • These drugs are effective in lowering blood pressure and reducing angina in various ethnic groups.

    • Conclusions:

    • Calcium antagonists are versatile cardiovascular agents.
    • Drug delivery innovations enhance therapeutic efficacy and patient compliance.
    • Effective across diverse populations including African Americans and whites.